2021
DOI: 10.1007/s11011-021-00746-z
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of γH2AX, COX-2 and regulation of antioxidant enzymes in MPP+-exposed SH-SY5Y cells pre-treated with rutin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 53 publications
0
8
0
Order By: Relevance
“…Further exploration of this exciting field in this model may elucidate the mechanisms of pathogenesis in PD. Because exploration of the new and reliable biomarkers of PD can eventually lead to the development of new treatment strategies (Enogieru et al, 2021), those manipulations such as using of inhibitor of DNA damage targeting the activation of DDR have potential intervention for the treatment of PD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Further exploration of this exciting field in this model may elucidate the mechanisms of pathogenesis in PD. Because exploration of the new and reliable biomarkers of PD can eventually lead to the development of new treatment strategies (Enogieru et al, 2021), those manipulations such as using of inhibitor of DNA damage targeting the activation of DDR have potential intervention for the treatment of PD.…”
Section: Discussionmentioning
confidence: 99%
“…The neural-specific vesicular monoamine transporter 2 (VMAT2) is a transmembrane protein and is a key regulator of monoamine homeostasis by implication in monoamine storage, protection of neurotransmitters from oxidation, and control of quantal secretion of these neurotransmitters (Erickson et al, 1992). Therefore, functional failure of VMAT2 has been recognized as a contributor to the pathology of PD (Lotharius & Brundin, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…In an earlier study, psoralen isolated from Dystaenia takeshimana was reported to inhibit COX-2/5-LOX in mouse bone marrow-derived mast cells [33]. A few studies suggest that psoralen derivatives [34,35] and rutin [36][37][38] possess COX-2 inhibitory activity. For instance, 5-methoxy-8-(2-hydroxy-3-buthoxy-3-methylbutyloxy)-psoralen from Angelica dahurica was reported to inhibit induction of COX-2 in bone marrow-derived mast cells [34].…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have claimed how 1-methyl-4-phenylpyridinium (MPP + )has been used in the induction of dopaminergic cell death [32]. In this study, 0.5 mmol of MPP + was induced to the SHSY5Y cell line to cause toxicity to the cells at 20 C, and the treatment was provided by the top % cell viability compounds HBU-2, and HBU-4 with a dose selectivity of 125 µg/ml.…”
Section: Neuroprotection Of Hbu-2 and Hbu-4mentioning
confidence: 99%